MDMA — Pharmala Biotech Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapFalling Star

Annual balance sheet for Pharmala Biotech Holdings, fiscal year end - August 31st, CAD millions except per share, conversion factor applied.

	2021 August 31st	2022 August 31st	2023 August 31st	2024 August 31st
Period Length:	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.47	0.852	0.195	0.419
Net Total Accounts Receivable
Net Total Receivables	0.06	0.051	0.223	0.211
Total Inventory
Prepaid Expenses
Total Current Assets	2.53	1.09	0.714	1.04
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.002	0.004	0.002	0
Net Intangible Assets
Total Assets	2.79	2.33	2.41	2.9
Payable / Accrued
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	0.138	0.424	1.03	0.917
Total Long Term Debt
Total Debt
Total Liabilities	0.138	0.424	1.03	0.917
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	2.66	1.91	1.38	1.98
Total Liabilities & Shareholders' Equity	2.79	2.33	2.41	2.9
Total Common Shares Outstanding